Weimin Wang

Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California.

Part of Blackstone, Inc., Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. is a Chinese company that provides investment management services. The company is based in Shime Yi, China.

DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China.

Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore.

VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China.

VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction.